Primo
Pharmacology detail: animal ratings
These ratios are not measured human benefit or safety rankings.
Primo is methenolone. Its oral and injectable forms have different esters and reference contexts.
Technical catalog description
Primobolan (Methenolone) is widely regarded as one of the safest and most well-tolerated anabolic steroids available, earning it the nickname ‘the gentleman’s steroid’ and ‘the connoisseur’s steroid.’
Available in both oral (Methenolone Acetate) and injectable (Methenolone Enanthate) forms, Primobolan is a DHT derivative that provides quality muscle gains with minimal side effects. The compound is particularly prized for its ability to preserve muscle mass during cutting phases while promoting a hard, defined appearance without water retention.
Read next
Mechanism details
Primobolan (methenolone) holds an unusual position in anabolic pharmacology: it is a DHT derivative that does not aromatize, has low androgenic activity, and produces what users consistently describe as high-quality, well-retained gains. The absence of estrogenic activity means no water retention, no gynecomastia risk, and no need for pharmaceutical aromatase inhibitors. Estrogen-sensitive users often find primo the most comfortable injectable compound available.
The injectable form (methenolone enanthate, “Primobolan Depot”) and oral form (methenolone acetate) have different bioavailability. This does not establish an oral-to-injectable dose conversion in this catalog.
The compound’s reputation for high gain retention post-cycle is mechanistically grounded: gains made without water retention and without estrogenic interference tend to be primarily lean tissue. When the cycle ends, there is no glycogen and estrogen-driven water to lose; what remains is more likely to be actual tissue added.
Natural suppression with reduced fertility and testicular output
Acne, oily skin, scalp hair loss, and prostate irritation in susceptible users
CBC / hematocrit
blood pressure
lipid panel
PSA if age or symptoms justify it
Uncontrolled hypertension or untreated cardiovascular disease
Pre-existing severe infertility concerns unless that risk is accepted and managed
Aggressive hair loss history or significant prostate symptoms
Primo is chosen when quality of gains matters more than speed of gains. The typical user profile is someone running a cutting or recomposition cycle who wants an anabolic base that preserves muscle under caloric deficit, does not require estrogen management, and produces a clean-looking result.
It is also popular as a second injectable for users who are already running testosterone and want an additional anabolic component without adding aromatization risk. Testosterone + Primo provides an estrogenic component (testosterone) and a non-estrogenic anabolic base (primo), which can be more nuanced and controllable than testosterone + another aromatizing compound.
Female users sometimes prefer primo injectable over Anavar for longer cycles because it allows titration to effect over a longer timeframe without the hepatic stress of oral use.
Primobolan Depot uses an enanthate ester. Onset is 2–3 weeks to meaningful blood levels; the compound is slow to build and slow to clear. The typical cycle length is 12–16 weeks because shorter durations do not allow the compound to deliver its full benefit.
Unverified community-use description: Users describe slow changes rather than immediate feedback. These accounts do not establish a cycle length.
Source reference information
Separate oral and injectable community ranges. Route and ester must be selected; no oral-to-injectable equivalence or midpoint default. References remain separate from quantities entered in a plan.
Reported range: 80–150 mg/day total. Source says at least once daily but does not define a fixed count. Reported oral methenolone range. Population: Male users described in community profile. Route: oral; formulation: Oral methenolone acetate. Anecdotal range, not a safety guarantee. Oral and injectable references are separate; no dose equivalence. Source: r/steroids: Primobolan.
Reported range: 200–400 mg/week total. Source describes once OR twice weekly. Reported injectable methenolone range. Population: Users reporting injectable use in community profile. Route: injection; formulation: Methenolone enanthate. Anecdotal report, not a clinically validated safe range. Do not transfer the amount or cadence to the oral acetate form. Source: r/steroids: Primobolan.
Treating community amounts as a minimum effective dose. This profile does not validate such a threshold or justify increasing an amount to meet it.
A related mistake is expecting rapid visual feedback. The compound rewards patience and a long-cycle lens.
Cost and supply issues drive another common mistake: substituting with Testosterone Enanthate (which looks identical and is cheaper to produce) or running under-dosed product. Testing or trusting sources with established track records is more important for primo than most compounds.
Compared with Masteron, primo is usually more sustainable, less androgenically harsh for hair-sensitive users, and better suited for longer cycles. Masteron is cheaper, produces a more acutely visible hardening effect, and has a faster practical onset. For cycles exceeding 12 weeks, primo is typically the better foundation compound.
Compared with Anavar, primo is injectable, better for cycles of 12+ weeks, and less hepatically stressful. Anavar is more convenient and produces slightly faster strength feedback. For maintenance cutting and recomposition over a long window, primo is the more sustainable choice.
Compared with Equipoise, primo has less hematocrit burden, no significant appetite elevation, and less androgenic exposure at equivalent doses. Equipoise users often report more dramatic appetite and cardiovascular effects. Primo produces a cleaner, less stimulating cycle for users who want to avoid those variables.